Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-04-04 Sale |
2022-04-05 08:17 am |
GENOCEA BIOSCIENCES INC. | GNCA | Davis Thomas Andrew CHIEF MEDICAL OFFICER |
1,091 | $1.25 | $1,364 | 68,330 (Direct) |
View |
2022-03-16 Sale |
2022-03-17 4:09 pm |
GENOCEA BIOSCIENCES INC. | GNCA | Davis Thomas Andrew CHIEF MEDICAL OFFICER |
2,717 | $1.1 | $2,989 | 163,171 (Direct) |
View |
2021-04-02 Sale |
2022-03-16 5:29 pm |
GENOCEA BIOSCIENCES INC. | GNCA | Davis Thomas Andrew CHIEF MEDICAL OFFICER |
1,472 | $2.5391 | $3,738 | 48,700 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2022-03-15 Option Award |
2022-03-17 4:09 pm |
N/A 2032-03-15 |
GENOCEA BIOSCIENCES INC. | GNCA | Davis Thomas Andrew CHIEF MEDICAL OFFICER |
125,000 | $0 | 163,171 (Direct) |
View |
2021-03-15 Option Award |
2021-03-17 1:50 pm |
N/A 2031-03-15 |
GENOCEA BIOSCIENCES INC. | GNCA | Davis Thomas Andrew CHIEF MEDICAL OFFICER |
225,000 | $0 | 225,000 (Direct) |
View |
2020-06-01 Option Award |
2020-06-02 4:24 pm |
N/A 2030-06-01 |
GENOCEA BIOSCIENCES INC. | GNCA | Davis Thomas Andrew CHIEF MEDICAL OFFICER |
31,561 | $0 | 31,561 (Direct) |
View |